Medibact GuidesShop at Medibact

Stacking Module

Mod GRF 1-29 Stacking Module

Mod GRF 1-29 is CJC-1295 without the DAC modification, and that identity is the single most important fact for stacking it. Much of the confusion in GH-axis stacks comes from sources treating the two as separate compounds that could be combined.

Mod GRF 1-29 Guide at MedibactMod GRF 1-29 calculatorPeptide Stacking Guide

Educational use only — not medical advice. This page summarizes information reported in published research and community practice for educational purposes. It is not medical advice and not a recommendation to use any compound. Any doses, schedules, or combinations shown are examples of what has been reported, not instructions for you. Many peptides described here are research compounds that are not FDA-approved for the uses discussed and may be investigational or restricted. Effects, risks, and legal status vary; individual needs and results vary. Consult a qualified, licensed healthcare professional before making any decision. Do not use this content to diagnose, treat, or dose yourself.

How to think about stacking Mod GRF 1-29

  • Mod GRF 1-29 and CJC-1295 no-DAC are the same thing. Combining them is not a stack, it is a duplicate.
  • Its half-life is minutes to hours, not days, so timing is a real variable rather than a formality.
  • It is a GHRH analog — the complementary partner is a ghrelin-receptor secretagogue.
  • No controlled trial has studied it combined with anything.

Combinations in detail

GH Pulse Stack

Mod GRF 1-29 + Ipamorelin
Why it is proposed
The two-pathway construction in its cleanest form: a short-acting GHRH analog producing a defined pulse alongside a selective secretagogue, with no DAC ambiguity to resolve.
What is reported in practice
Commonly reported at roughly 1:1 microgram amounts drawn together, fasted, often at bedtime.
Cautions specific to this combination
The 1:1 convention is community practice rather than a studied ratio. The short half-life means administration timing relative to food is treated as consequential in reported protocols.

Recovery / Repair Stack

Mod GRF 1-29 + Ipamorelin + BPC-157 + TB-500
Why it is proposed
GH-axis support plus the local repair pairing — genuinely separate mechanisms.
What is reported in practice
Separate vials on separate schedules; the GH pair together, the repair compounds independently.
Cautions specific to this combination
Four compounds with four different scales (micrograms for the GH pair and BPC-157, milligrams for TB-500). Recompute each rather than carrying figures across.

Skin & Connective Tissue Stack

Mod GRF 1-29 + Ipamorelin + GHK-Cu
Why it is proposed
Adds copper-peptide matrix remodeling to GH-axis support, on the premise that systemic and local tissue mechanisms differ.
What is reported in practice
Reported as separate vials; GHK-Cu's own literature is strongest topically.
Cautions specific to this combination
GHK-Cu adds cumulative copper exposure, a constraint the GH compounds do not carry — it should govern duration independently.

What to avoid, and why

  • Combining Mod GRF 1-29 with CJC-1295 — they are the same peptide, differing only by the DAC modification.
  • Pairing two GHRH analogs (Sermorelin, CJC-1295, Mod GRF 1-29, Tesamorelin) is described as redundant rather than additive — they act at the same receptor. Mod GRF 1-29 is CJC-1295 without the DAC modification, so combining those two is close to running one compound against itself.
  • Adding a second secretagogue alongside Ipamorelin.

Related reading

The Peptide Stacking GuideAll stacking pages

Every combination described here is reported practice or mechanism-level reasoning. No controlled trial has studied any of these combinations, and nothing on this page is a personal protocol, a dose recommendation, or medical advice.